Analystreport

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) had its price target lowered by analysts at SVB Leerink LLC from $66.00 to $62.00. They now have an "outperform" rating

Rocket Pharmaceuticals, Inc.  (RCKT) 
Last rocket pharmaceuticals, inc. earnings: 3/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: rocketpharma.com